George Ueda
George Ueda is Co-Founder and CTO at Archon Biosciences, a startup focused on designed protein therapeutics. His expertise includes developing protein therapeutics.
Archon's Jamie Lazarovits on Unlocking the Full Power of Antibodies With AI
What does it take to move from cutting-edge academic research to launching a biotech company that could transform medicine? In this week's episode of Founded & Funded, Madrona Partner Chris Picardo sat down with Jamie Lazarovitz, CEO and co-founder of Archon Biosciences, to uncover the story behind their groundbreaking protein-based biologics and their unique Antibody Cages (AbCs). From bootstrapping deep tech investments as a student to navigating the challenges of commercializing revolutionary science, Jamie shares the pivotal moments, tough decisions, and key lessons that led to Archon's creation. This isn't just a story for biotech enthusiasts — every founder can…
Archon Biosciences Raises $20M to Develop AI-Optimized Antibody Cages for Disease Treatment
Archon Biosciences has emerged from stealth with $20 million in seed funding led by Madrona Ventures to develop Antibody Cages, computationally designed protein structures optimized with AI for treating cancer and other diseases. The technology builds on protein design research linked to a recent Nobel Prize awarded to University of Washington biochemist David Baker.
Organizations
See all 7-
Archon Biosciences Co-Founder and CTO 2023–present · current
-
Institute for Protein Design, University of Washington Acting Instructor - Translational Investigator 2021–2024 · past
-
Lumen Biosciences Consultant 2018 · past
Education
-
UW Medicine Doctor of Philosophy - PhD, Biochemistry · 2013–2018
-
University of Washington Bachelor of Science (BS), Biochemistry · 2009–2013
